BridgeBio is substantially improved its development of a novel treatment for ATTR-CM, leveraging the compound. Initial trial information indicates significant benefits for those diagnosed by the severe illness. This https://bridgebio553763.bcbloggers.com/40874581/bridgebio-advances-cardiac-amyloidosis-treatment-with-attruby